Antonio Sica
#116,374
Most Influential Person Now
Researcher
Antonio Sica's AcademicInfluence.com Rankings
Download Badge
Physics
Antonio Sica's Degrees
- PhD Physics University of Milan
- Masters Physics University of Milan
- Bachelors Physics University of Milan
Why Is Antonio Sica Influential?
(Suggest an Edit or Addition)Antonio Sica's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cancer-related inflammation (2008) (9454)
- The chemokine system in diverse forms of macrophage activation and polarization. (2004) (5622)
- Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. (2002) (4728)
- Macrophage plasticity and polarization: in vivo veritas. (2012) (4585)
- Macrophage activation and polarization: nomenclature and experimental guidelines. (2014) (4128)
- Macrophage activation and polarization. (2008) (2890)
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. (2009) (2522)
- Macrophage plasticity and polarization in tissue repair and remodelling (2013) (1842)
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards (2016) (1817)
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. (2006) (1396)
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity. (2010) (1339)
- Altered macrophage differentiation and immune dysfunction in tumor development. (2007) (1250)
- Macrophage polarization comes of age. (2005) (1141)
- Macrophage polarization in tumour progression. (2008) (1113)
- Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. (2014) (993)
- The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. (2008) (909)
- Regulation of the Chemokine Receptor CXCR4 by Hypoxia (2003) (865)
- Role of tumor-associated macrophages in tumor progression and invasion (2006) (833)
- A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). (2006) (713)
- A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter (1995) (671)
- Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB (2009) (588)
- The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance (2008) (586)
- Cancer related inflammation: the macrophage connection. (2008) (548)
- Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 (2000) (473)
- p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. (2006) (469)
- New vistas on macrophage differentiation and activation (2007) (455)
- Macrophage polarization in pathology (2015) (425)
- Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms1 (2008) (409)
- Interaction of NF-κB and NFAT with the Interferon-γ Promoter* (1997) (408)
- Pathways connecting inflammation and cancer. (2008) (399)
- Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. (1990) (378)
- A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. (2009) (352)
- Macrophage plasticity and polarization in liver homeostasis and pathology (2014) (351)
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. (2009) (343)
- Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. (2004) (330)
- Macrophage activation and polarization as an adaptive component of innate immunity. (2013) (329)
- Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes (1997) (326)
- Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α* (2005) (298)
- Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. (2002) (287)
- Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes (1998) (265)
- Cellular and molecular pathways linking inflammation and cancer. (2009) (258)
- M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro1 (2009) (251)
- Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. (1997) (236)
- Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. (2004) (208)
- Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. (2009) (207)
- Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. (1991) (206)
- The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. (1993) (201)
- The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues (2000) (197)
- Molecular and epigenetic basis of macrophage polarized activation. (2015) (190)
- IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. (1990) (180)
- Divergent effects of hypoxia on dendritic cell functions. (2008) (168)
- Characterization of the Promoter for the Human Long Pentraxin PTX3 (1997) (159)
- Inflammation and cancer: breast cancer as a prototype. (2007) (154)
- Negative Transcriptional Regulation of the Interferon-γ Promoter by Glucocorticoids and Dominant Negative Mutants of c-Jun (*) (1995) (151)
- Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. (1998) (148)
- Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. (2005) (147)
- RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis. (2015) (144)
- Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1 (2000) (142)
- Myeloid suppressor cells in cancer and autoimmunity. (2017) (140)
- The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. (1992) (131)
- Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors (2019) (129)
- Tumor-associated macrophages: a molecular perspective. (2002) (128)
- Redox regulation of chemokine receptor expression. (2000) (123)
- Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. (1995) (123)
- Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies (2016) (117)
- Role of tumour-associated macrophages in cancer-related inflammation. (2010) (114)
- Expression of a heat-inducible gene of the HSP70 family in human myelomonocytic cells: regulation by bacterial products and cytokines. (1991) (114)
- Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages. (2017) (113)
- Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out. (2019) (111)
- Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection (2021) (106)
- Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. (1991) (105)
- Mechanisms linking pathogens-associated inflammation and cancer. (2011) (102)
- Regulation of PD-L1 Expression by NF-κB in Cancer (2020) (102)
- Tumor promotion by tumor-associated macrophages. (2007) (99)
- Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. (1994) (94)
- A chemoattractant expressed in human sarcoma cells (tumor‐derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein‐1/monocyte chemotactic and activating factor (MCP‐1/MCAF) (1990) (90)
- Inflammation as target in cancer therapy. (2017) (89)
- Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7‐dependent manner (2014) (88)
- Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. (2013) (87)
- Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. (2002) (86)
- Cell-specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells* (2008) (84)
- Hypoxia-mediated regulation of macrophage functions in pathophysiology. (2013) (81)
- Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs) (2012) (81)
- MCP‐1 and CCR2 in HIV infection: regulation of agonist and receptor expression (1997) (78)
- Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel (1992) (75)
- Targeting tumour-associated macrophages (2007) (71)
- Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. (2004) (70)
- miR-146a and NF-κB1 Regulate Mast Cell Survival and T Lymphocyte Differentiation (2012) (68)
- Myeloid-Derived Suppressor Cells: Ductile Targets in Disease (2019) (67)
- Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations (2003) (64)
- Hypoxia: a double-edged sword of immunity (2011) (63)
- Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs (2020) (59)
- Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-γ Promoter* (1996) (58)
- Expression of CD4 on human peripheral blood neutrophils. (2003) (58)
- Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs (2014) (58)
- Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase (2010) (56)
- Activation of Nuclear Factor of Activated T Cells in a Cyclosporin A-resistant Pathway (*) (1996) (55)
- Expression of c-jun protooncogene in human myelomonocytic cells. (1989) (52)
- Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530 (2018) (52)
- Correction tp Macrophage activation and polarization: Nomenclature and experimental guidelines [Immunity, 41, 2014 (14-20)] (2014) (51)
- Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization (2013) (51)
- Tumor‐associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy (2018) (47)
- Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation (2013) (47)
- Linking inflammation reactions to cancer: novel targets for therapeutic strategies. (2008) (46)
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells. (2019) (45)
- Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target (2009) (45)
- Regulation of macrophage function in tumors: the multifaceted role of NF- B (2009) (44)
- Tumor-associated myeloid cells as guiding forces of cancer cell stemness (2017) (42)
- Up-regulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones. (1999) (42)
- Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. (2012) (41)
- Energy metabolism drives myeloid‐derived suppressor cell differentiation and functions in pathology (2017) (40)
- Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad (2020) (37)
- Heme catabolism by tumor-associated macrophages controls metastasis formation (2021) (36)
- Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression (2018) (35)
- Convergent pathways of macrophage polarization: The role of B cells (2010) (34)
- SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities (2019) (34)
- Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. (2011) (33)
- Endothelial cells express the interleukin-1 receptor type I (1991) (30)
- Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression (2019) (29)
- VEGF blockade enhances the antitumor effect of BRAFV 600E inhibition (2016) (28)
- Metabolic regulation of suppressive myeloid cells in cancer. (2017) (27)
- Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. (1991) (27)
- IL‐10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF‐κB p50 member in Trypanosoma congolense infection‐resistant C57BL/6 mice (2011) (26)
- Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration. (2010) (25)
- Metabolic influence on the differentiation of suppressive myeloid cells in cancer. (2018) (23)
- GADD45β Loss Ablates Innate Immunosuppression in Cancer. (2017) (23)
- Divergent effects of dithiocarbamates on AP‐1‐containing and AP‐1‐less NFAT sites (1999) (22)
- Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases (2022) (21)
- developmental relationships embryonic macrophages suggests common functions and Tie 2-expressing monocytes , blood ' ' resident ' ' monocytes , and A distinguishing gene signature shared by tumor-infiltrating (2009) (21)
- Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages (2020) (21)
- Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. (1996) (20)
- The p50 Subunit of NF-κB Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity (2012) (20)
- Immunometabolic Status of COVID-19 Cancer Patients (2020) (20)
- Influence of Innate Immunity on Cancer Cell Stemness (2020) (19)
- Endothelial cells express the interleukin-1 receptor type I. (1991) (18)
- The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance (2020) (17)
- Interleukin-6 gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae. (1990) (17)
- Tumor-associated macrophages (TAMs) as new target in anticancer therapy (2006) (16)
- Cellular and molecular pathways linking inflammation and cancer. Immunobiology (2009) (14)
- Implications of metabolism-driven myeloid dysfunctions in cancer therapy (2020) (14)
- Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity. (2018) (11)
- Impact of cholesterolemia and body mass index on outcome of metastatic non small cell lung cancer treated with immunotherapy. (2019) (9)
- Oncolytic virotherapy: new weapon for breast cancer treatment (2020) (8)
- A PROTEOMIC ANALYSIS OF GSD-1a IN MOUSE LIVERS: EVIDENCE FOR METABOLIC REPROGRAMMING, INFLAMMATION AND MACROPHAGE POLARIZATION. (2019) (8)
- LPS‐inducible nuclear factor in human monocytes that binds the negative regulatory element of the HIV LTR (1994) (8)
- The role of cytokines as communication signals between leukocytes and endothelial cells. (1990) (8)
- Membrane Cholesterol Regulates Macrophage Plasticity in Cancer. (2019) (8)
- Tolerance in intestinal inflammation and cancer. (2008) (7)
- Macrophages give Gas(6) to cancer. (2010) (7)
- Macrophage fusion cuisine. (2009) (7)
- Tumors as a Paradigm for the In Vivo Role of Chemokines in Leukocyte Recruitment (1999) (5)
- Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-g Promoter* (1996) (5)
- The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis (2018) (4)
- Precision Medicine Approaches with Metabolomics and Artificial Intelligence (2022) (3)
- Role of Tumor‐Associated Macrophages (TAM) in Cancer Related Inflammation (2010) (3)
- RORC 1 Regulates Tumor-Promoting ‘ ‘ Emergency ’ ’ Granulo-Monocytopoiesis Graphical Abstract Highlights (3)
- Retraction notice to: Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. (2014) (3)
- The interleukin 2 CD 28-responsive complex contains at least three members of the NF cB family : c-Rel , p 50 , and p 65 (2005) (3)
- Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis (2022) (3)
- NF-KappaB-Mediated Regulation of Tumour-Associated Macrophages: Mechanisms and Significance (2011) (3)
- Tumor-Infiltrating Inflammatory Cells as Possible Therapeutic Targets (2012) (3)
- Tumor-Associated Macrophages (2014) (2)
- Tumor-Associated Macrophages in Cancer Growth and Progression (2007) (2)
- Response to Hellstrand: The jury on radicals is still out (2003) (2)
- Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective (2022) (2)
- The Yin Yang of Cancer Related Inflammation (2011) (2)
- Title: Enhanced interferon regulatory factor 3 binding to the IL-23p19 promoter correlates with enhanced IL-23 expression in systemic lupus erythematosus. Running Title: IRF3-IL-23p19 promoter interaction in SLE (2011) (1)
- Abstract 393: Nicotinamide phosphoribosyl transferase (NAMPT) inhibitors: novel modulators of antitumor immunity (2015) (1)
- Antitumor Resistance Macrophages Inhibits M 1 Inflammatory Responses and B Overexpression in Tumor-Associated κ p 50 Nuclear Factor-Updated (2006) (1)
- MacrophagesActivation in Tumor-Associated B k Defective IL-12 Production and NF-Autocrine Production of IL-10 Mediates (1999) (1)
- Chapter 27 – Tumor-associated Macrophages in Cancer Growth and Progression (2013) (1)
- Inflammation and cancer: From bench to bedside? (2007) (1)
- 166 p50 NF-κB overexpression in tumor associated macrophages inhibits M1 inflammatory responses and antitumor resistance (2008) (1)
- Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer. (2022) (1)
- 2 Functions of Diverse Myeloid Cells in the Tumor MicroEnvironment (2017) (0)
- Molecular Mechanisms Tumor Progression: Regulation by Distinct Plasticity of Macrophage Function during (2008) (0)
- SP0104 Reprogramming of myeloid cells in cancer: mechanisms and significance (2017) (0)
- The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment (2009) (0)
- Macrophages (PP-047) (2010) (0)
- Dendritic cells: function (PP-024) (2010) (0)
- The Immunoglobulin Heavy Chain Gene 2122 1 8 M a R C H 2 0 1 0 I V O L U M E 1 1 5 , N U M B E R 1 1 Blood (0)
- Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. (2011) (0)
- 296 Macrophage migration in tolerance (2010) (0)
- Abstract 2677: Role of CLEC4D in inflammation-driven liver carcinogenesis (2017) (0)
- Immunometabolic interference between cancer and COVID-19 (2023) (0)
- Correction: Convergent pathways of macrophage polarization: The role of B cells (2010) (0)
- Role of p50 NF-kappaB in dendritic cells functions (2008) (0)
- Modulation of p50 NF-kappaB activity in TAM and TADC : a possible novel strategy to restore antitumor functions in vivo (2007) (0)
- Host metabolic factors and prognosis in patients treated with immune checkpoint inhibitors for advanced malignancies. (2019) (0)
- MiR-146 a and NF-kB 1 regulate mast cell survival and T lymphocyte 1 differentiation 2 3 4 (2012) (0)
- Cancer immunity and immunotherapy beyond COVID-19 (2023) (0)
- Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020 (2022) (0)
- The c-rel protooncogene product c-Rel but not NF-KB (2004) (0)
- PD-L1 status and efficacy of immune check-point inhibitors (ICIs) in advanced cancer patients: A pooled analysis of randomized trials. (2020) (0)
- Regulation of Inflammatory Cytokine Receptor Expression by Pro- and Anti-Inflammatory Molecules (1998) (0)
- IRF-3/STAT1 activation B and enhanced κ tumor-associated macrophages: defective NF- A distinct and unique transcriptional programme expressed by (2013) (0)
- Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy (2021) (0)
- NF‐κBとNFATのインターフェロン‐γのプロモータとの相互作用 (1997) (0)
- Ovarian Carcinoma Macrophages Associated with Human Chemotactic Protein-1 Receptor CCR 2 in Defective Expression of the Monocyte (1999) (0)
- Nicotinamide Phosphoribosyl Transferase ( NAMPT ) Inhibitors : Novel Modulators of Cancer-Related Inflammation (2013) (0)
- T Lymphocyte Infiltration Antitumoral Immune Response by Promoting Dendritic Cell Inactivation of Junctional Adhesion Molecule-A Enhances (2010) (0)
- Abstract 1871: Targeting nicotinamide phosphoribosyltransferase (NAMPT) in cancer therapy. (2013) (0)
- PS2-039. The p50 NF-κB subunit controls dendritic cell survival and immunogenicity (2011) (0)
- PP-046-32 IL-32g induces maturation of dendritic cells through a NF-kB/p38 MAPK signaling pathway (2010) (0)
- The central nervous system microenvironment imprints microglial inability to switch from pro- to anti-inflammatory phenotype (2014) (0)
- IL-21 and T follicular helper cells (2013) (0)
- Abstract PR04: Targeting tumor-asoociated macrophages with a novel anti-CSF1R antibody in cancer patients (2015) (0)
- Abstract P3-05-09: mRNA expression level and prognostic significance of different immune-related biomarkers in early breast cancer (2020) (0)
- Macrophages (WS-047) Chairpersons: Masato Tanaka, Anna Erdei (2010) (0)
- More Efficiently than M 1 Cells In Vitro Rituximab-Opsonized Leukemic Targets M 2 Macrophages Phagocytose (2009) (0)
- Functions of Diverse Myeloid Cells in the Tumor Micro-Environment (2012) (0)
- IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-jB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice: Eur. J. Immunol. 2011 41:1-11 (2011) (0)
- Macrophage polarization in pathology (2015) (0)
- The p50 NF-κB subunit is a prognostic regulator of colorectal cancer-associated inflammation (2016) (0)
- Modulation of Innate Immunity by Hypoxia (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Antonio Sica?
Antonio Sica is affiliated with the following schools:
